157 related articles for article (PubMed ID: 14687169)
1. A pilot study to investigate the use of oxpentifylline (pentoxifylline) and thalidomide in portal hypertension secondary to alcoholic cirrhosis.
Austin AS; Mahida YR; Clarke D; Ryder SD; Freeman JG
Aliment Pharmacol Ther; 2004 Jan; 19(1):79-88. PubMed ID: 14687169
[TBL] [Abstract][Full Text] [Related]
2. An open study of pentoxyfylline and thalidomide as adjuvant therapy in the treatment of rheumatoid arthritis.
Huizinga TW; Dijkmans BA; van der Velde EA; van de Pouw Kraan TC; Verweij CL; Breedveld FC
Ann Rheum Dis; 1996 Nov; 55(11):833-6. PubMed ID: 8976641
[TBL] [Abstract][Full Text] [Related]
3. Acute haemodynamic responses and inhibition of tumour necrosis factor-alpha by pentoxifylline in rats with cirrhosis.
Soupison T; Yang S; Bernard C; Moreau R; Kirstetter P; D'Almeida M; Cailmail S; Tedgui A; Lebrec D
Clin Sci (Lond); 1996 Jul; 91(1):29-33. PubMed ID: 8774257
[TBL] [Abstract][Full Text] [Related]
4. Clinical vs haemodynamic response to drugs in portal hypertension.
McCormick PA; Patch D; Greenslade L; Chin J; McIntyre N; Burroughs AK
J Hepatol; 1998 Jun; 28(6):1015-9. PubMed ID: 9672178
[TBL] [Abstract][Full Text] [Related]
5. Pentoxifylline, a drug with rheological effects, decreases portal pressure in an experimental model of cirrhosis.
Sánchez S; Albornoz L; Bandi JC; Gerona S; Mastai R
Eur J Gastroenterol Hepatol; 1997 Jan; 9(1):27-31. PubMed ID: 9031895
[TBL] [Abstract][Full Text] [Related]
6. Possible deleterious hemodynamic effect of nifedipine on portal hypertension in patients with cirrhosis.
Koshy A; Hadengue A; Lee SS; Jiron MI; Lebrec D
Clin Pharmacol Ther; 1987 Sep; 42(3):295-8. PubMed ID: 3621783
[TBL] [Abstract][Full Text] [Related]
7. Endotoxin and tumor necrosis factor-receptor levels in portal and hepatic vein of patients with alcoholic liver cirrhosis receiving elective transjugular intrahepatic portosystemic shunt.
Trebicka J; Krag A; Gansweid S; Appenrodt B; Schiedermaier P; Sauerbruch T; Spengler U
Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1218-25. PubMed ID: 21971377
[TBL] [Abstract][Full Text] [Related]
8. Haemodynamic effects of molsidomine and propranolol in patients with cirrhosis.
Combis JM; Vinel JP; Badia P; Barange K; Payen JL; Combis F; Desmorat H; Pascal JP
Br J Clin Pharmacol; 1996 May; 41(5):409-13. PubMed ID: 8735682
[TBL] [Abstract][Full Text] [Related]
9. Treatment with tumour necrosis factor inhibitor oxpentifylline does not improve corticosteroid dependent chronic active Crohn's disease.
Bauditz J; Haemling J; Ortner M; Lochs H; Raedler A; Schreiber S
Gut; 1997 Apr; 40(4):470-4. PubMed ID: 9176073
[TBL] [Abstract][Full Text] [Related]
10. Effects of isosorbide dinitrate on portal hypertension in alcoholic cirrhosis.
Merkel C; Finucci G; Zuin R; Bazzerla G; Bolognesi M; Sacerdoti D; Gatta A
J Hepatol; 1987 Apr; 4(2):174-80. PubMed ID: 3584925
[TBL] [Abstract][Full Text] [Related]
11. [Effect of pentoxifylline on survival, cardiac function and both portal and systemic hemodynamics in advanced alcoholic cirrhosis--a randomized double-blind placebo-controlled trial].
Fernández-Rodríguez CM; Lledó JL; López-Serrano P; Gutiérrez ML; Alonso S; Pérez-Fernández MT; Fernández Gil M; Pazos R; Tolon R; Hernández T; Sanz P
Rev Esp Enferm Dig; 2008 Aug; 100(8):481-9. PubMed ID: 18942901
[TBL] [Abstract][Full Text] [Related]
12. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
[TBL] [Abstract][Full Text] [Related]
13. Interaction of thalidomide, phthalimide analogues of thalidomide and pentoxifylline with the anti-tumour agent 5,6-dimethylxanthenone-4-acetic acid: concomitant reduction of serum tumour necrosis factor-alpha and enhancement of anti-tumour activity.
Ching LM; Browne WL; Tchernegovski R; Gregory T; Baguley BC; Palmer BD
Br J Cancer; 1998 Aug; 78(3):336-43. PubMed ID: 9703279
[TBL] [Abstract][Full Text] [Related]
14. Pentoxifylline and thalidomide fail to reduce hepatic steatosis during total parenteral nutrition and bowel rest in the rat.
Vromen A; Spira RM; Bercovier H; Berry E; Freund HR
JPEN J Parenter Enteral Nutr; 1997; 21(4):233-4. PubMed ID: 9252951
[TBL] [Abstract][Full Text] [Related]
15. Pilot study of pentoxifylline in hepatopulmonary syndrome.
Tanikella R; Philips GM; Faulk DK; Kawut SM; Fallon MB
Liver Transpl; 2008 Aug; 14(8):1199-203. PubMed ID: 18668653
[TBL] [Abstract][Full Text] [Related]
16. Tumour necrosis factor alpha is an important mediator of portal and systemic haemodynamic derangements in alcoholic hepatitis.
Mookerjee RP; Sen S; Davies NA; Hodges SJ; Williams R; Jalan R
Gut; 2003 Aug; 52(8):1182-7. PubMed ID: 12865279
[TBL] [Abstract][Full Text] [Related]
17. Portal hemodynamics during nitroglycerin administration in cirrhotic patients.
Garcia-Tsao G; Groszmann RJ
Hepatology; 1987; 7(5):805-9. PubMed ID: 3115881
[TBL] [Abstract][Full Text] [Related]
18. Relationship between degree of portal hypertension and liver histologic lesions in patients with alcoholic cirrhosis. Effect of acute alcoholic hepatitis on portal hypertension.
Poynard T; Degott C; Munoz C; Lebrec D
Dig Dis Sci; 1987 Apr; 32(4):337-43. PubMed ID: 3829877
[TBL] [Abstract][Full Text] [Related]
19. The effect of propranolol on portal hypertension in patients with cirrhosis: a hemodynamic study.
Lebrec D; Hillon P; Muńoz C; Goldfarb G; Nouel O; Benhamou JP
Hepatology; 1982; 2(5):523-7. PubMed ID: 6981575
[TBL] [Abstract][Full Text] [Related]
20. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure.
Theodorakis NG; Wang YN; Korshunov VA; Maluccio MA; Skill NJ
World J Gastroenterol; 2015 Apr; 21(14):4126-35. PubMed ID: 25892862
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
